Equity
RM PHYSIO has made a profit without a break since 2020.
RM PHYSIO has made a profit without a break since 2020.
The micro format states no turnover.
Short-term debts fell from €10,945 to €3,083.
The 2022 accounts came latest: 28 days after the end of the period.
Higher solvency than 94% of companies in human health. Sector median 63.0% · 21,311 companies.
In July 2024, 26,973 companies had the same profile as RM PHYSIO has now. Each dot stands for 68 companies, two years later.
Another 0.1% stopped without a precise date, possibly only after those two years.
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 26,973 companies, not a prediction for RM PHYSIO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
| Company | ||||
|---|---|---|---|---|
| RM PHYSIO Flobecq | €99,727 | €40,153 | 96.9% | - |
| Podoconsult Vansteenland Irene Lievegem | €116,534 | €38,640 | 43.7% | 0 |
| VIDONI Anderlues | €114,142 | €37,375 | 37.4% | - |
| MARIE VLS Tournai | €74,264 | €42,129 | 52.4% | - |
| SP Care Mons | €99,270 | €33,443 | 11.4% | - |
| FourD Ecaussinnes | €101,142 | €50,109 | 39.3% | - |
| MAXIME RAGNO KINESITHERAPEUTE Chapelle-lez-Herlaimont | €120,752 | €49,242 | 24.8% | - |
These companies have the same main activity as RM PHYSIO: physiotherapy (NACE 86951). They are comparable in size and age: total assets between €74,300 and €121,000, founded between 2017 and 2020.
RM PHYSIO files the micro format. That format states no turnover. The gross margin rose from €10,847 in 2019 to €40,153 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €120,000. Estimated: probably between €92,000 and €170,000.
Higher than 95% of 21,311 companies in 2025.
Higher than 95% of 20,862 companies in 2025.
Higher than 50% of 21,162 companies in 2025.
Net result: middle half · Equity: middle half · Balance sheet total: bottom quarter · Working capital: middle half
| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Balance sheet: assets | ||||||||
20/58 |
99,727 | 87,238 | 75,039 | 55,452 | 48,804 | 49,034 | 36,776 | |
21/28 |
1,603 | 3,851 | 6,077 | 1,173 | 10,096 | 19,018 | 27,941 | |
22/27 |
1,603 | 3,851 | 6,077 | 1,173 | 10,096 | 19,018 | 27,941 | |
24 |
855 | 3,001 | 5,126 | 1,173 | 10,096 | 19,018 | 27,941 | |
26 |
749 | 850 | 951 | - | - | - | - | |
29/58 |
98,124 | 83,387 | 68,962 | 54,278 | 38,708 | 30,016 | 8,835 | |
29 |
53,238 | 54,695 | 25,997 | 27,035 | - | - | - | |
290 |
53,238 | 54,695 | - | - | - | - | - | |
291 |
- | - | 25,997 | 27,035 | - | - | - | |
40/41 |
- | - | - | - | 605 | - | - | |
40 |
- | - | - | - | 605 | - | - | |
54/58 |
24,164 | 9,865 | 21,210 | 10,336 | 25,668 | 28,903 | 7,773 | |
490/1 |
20,722 | 18,827 | 21,755 | 16,907 | 12,435 | 1,113 | 1,062 | |
| Balance sheet: equity and liabilities | ||||||||
10/49 |
99,727 | 87,238 | 75,039 | 55,452 | 48,804 | 49,034 | 36,776 | |
10/15 |
96,644 | 76,293 | 60,082 | 37,769 | 25,118 | 11,594 | 647 | |
10/11 |
1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | |
100 |
- | - | - | - | - | - | 1,000 | |
11 |
- | - | - | - | - | 1,000 | - | |
1109/19 |
- | - | - | - | - | 1,000 | - | |
13 |
85,849 | 65,499 | 49,287 | 26,975 | 13,524 | - | - | |
133 |
85,849 | 65,499 | 49,287 | 26,975 | 13,524 | - | - | |
14 |
9,794 | 9,794 | 9,794 | 9,794 | 10,594 | 10,594 | -353 | |
17/49 |
3,083 | 10,945 | 14,957 | 17,683 | 23,686 | 37,440 | 36,129 | |
17 |
- | - | - | 7,070 | 13,002 | 18,819 | 24,561 | |
170/4 |
- | - | - | 7,070 | 13,002 | 18,819 | 24,561 | |
42/48 |
3,083 | 10,945 | 14,957 | 10,613 | 10,684 | 18,621 | 11,568 | |
42 |
- | - | - | 5,932 | 5,816 | 5,703 | 5,601 | |
44 |
1,284 | 345 | 1,495 | 1,926 | 251 | 1,045 | 446 | |
440/4 |
1,284 | 345 | 1,495 | 1,926 | 251 | 1,045 | 446 | |
45 |
1,800 | 9,800 | 12,662 | 1,955 | 2,368 | 3,842 | 881 | |
450/3 |
1,800 | 9,800 | 12,662 | 1,955 | 2,368 | 3,842 | 881 | |
47/48 |
- | 800 | 800 | 800 | 2,249 | 8,031 | 4,640 | |
| Income statement | ||||||||
76A |
- | - | 18,742 | - | - | - | - | |
9900 |
40,153 | 30,872 | 37,264 | 28,324 | 29,427 | 25,117 | 10,847 | |
630 |
2,247 | 2,226 | 1,373 | 8,923 | 8,922 | 8,923 | 7,749 | |
640/8 |
5,779 | 849 | 1,078 | 862 | 787 | 1,155 | 2,993 | |
9901 |
32,127 | 27,797 | 34,812 | 18,539 | 19,718 | 15,039 | 105 | |
75/76B |
1,528 | 1,142 | 1,501 | 744 | - | 0 | - | |
75 |
1,528 | 1,142 | 1,501 | 744 | - | 0 | - | |
65/66B |
2,079 | 2,690 | 2,494 | 439 | 888 | 1,131 | 139 | |
65 |
2,079 | 2,690 | 2,494 | 439 | 888 | 1,131 | 139 | |
9903 |
31,575 | 26,250 | 33,820 | 18,845 | 18,830 | 13,909 | -34 | |
67/77 |
11,225 | 9,239 | 10,707 | 5,394 | 5,306 | 2,961 | 320 | |
9904 |
20,351 | 17,011 | 23,113 | 13,451 | 13,524 | 10,947 | -353 | |
9905 |
20,351 | 17,011 | 23,113 | 13,451 | 13,524 | 10,947 | -353 | |
| Appropriation of the result | ||||||||
9906 |
30,145 | 26,805 | 32,907 | 24,045 | 24,118 | 10,594 | -353 | |
14P |
9,794 | 9,794 | 9,794 | 10,594 | 10,594 | - | - | |
691/2 |
20,351 | 16,211 | 22,313 | 13,451 | 13,524 | - | - | |
6921 |
20,351 | 16,211 | 22,313 | 13,451 | 13,524 | - | - | |
694/7 |
- | 800 | 800 | 800 | - | - | - | |
694 |
- | 800 | 800 | 800 | - | - | - | |
| Document | ||||||||
The notes to these accounts have 4 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 11-08-2026.
2025 annual accounts filed 11 days after the deadline. Filed on 11 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00401353.
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 11-08-2026 | 2026-00401353 | |
| 31-12-2024 | micro format | 03-07-2025 | 2025-00237678 | |
| 31-12-2023 | micro format | 01-07-2024 | 2024-00201022 | |
| 31-12-2022 | micro format | 28-08-2023 | 2023-00359551 | |
| 31-12-2021 | micro format | 25-07-2022 | 2022-20231710 | |
| 31-12-2020 | micro format | 12-08-2021 | 2021-48000066 | |
| 31-12-2019 | micro format | 27-08-2020 | 2020-48300594 |
| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| 34,374 | 30,023 | 36,185 | 27,462 | 28,641 | 23,962 | 7,854 | ||
| 22,598 | 19,237 | 24,486 | 22,374 | 22,446 | 19,870 | 7,396 | ||
| 0 | 0 | 7,450 | 0 | 0 | 0 | 35,690 | ||
| 14,299 | -11,345 | 10,874 | -15,332 | -3,235 | 21,130 | - | ||
| 95,040 | 72,442 | 54,005 | 43,666 | 28,024 | 11,395 | -2,733 | ||
| 96.9% | 87.5% | 80.1% | 68.1% | 51.5% | 23.6% | 1.8% | ||
| 31.82 | 7.62 | 4.61 | 5.11 | 3.62 | 1.61 | 0.76 | ||
| 0.03 | 0.14 | 0.25 | 0.47 | 0.94 | 3.23 | - | ||
| 21.1% | 22.3% | 38.5% | 35.6% | 53.8% | 94.4% | - | ||
| 20.4% | 19.5% | 30.8% | 24.3% | 27.7% | 22.3% | -1.0% | ||
| 16.53 | 11.16 | 14.51 | 62.60 | 32.24 | - | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible fixed assets | - | - | €7,450 | - | - |
| €2,247 | €2,226 | €1,373 | €8,923 | €8,922 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
The operating result for 2025 is 16% higher than in 2024. It is a recovery after the fall in 2024.
Debt's share of the balance-sheet total falls from 12.5% to 3.1%. Equity is higher and debt is lower.
RM PHYSIO has no parent and no holdings in its annual accounts. is the only director.
| Sablon, Coralie (sole trader)
establishment since 03-10-2016 |
founded in 2016 0665.556.095 |
via , no longer at · Director · deed of 22-09-2023 founded in 1995 |
9 FTE (2025) |
The network starts from the earlier ties.
Deadline for the 2026 accounts: 31-07-2027
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
| Establishment | Since | Unit number |
|---|---|---|
| Lieutenant Cottonstraat 6 registered office 7880 Flobecq | 21-02-2019 | 2.287.246.340 |
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 51019B0020/00G000 | 1,058 m² | 1 · 125 m² | 11.6 m · 3 |
If something looks wrong or is missing, please tell us.